Carregant...

Experience with a novel efalizumab-based immunosuppressive regimen to facilitate single donor islet cell transplantation

Islet transplantation is an experimental therapy for selected patients with type 1-diabetes (T1DM). It remains limited by immunosuppressive drug toxicity, progressive loss of insulin independence, allosensitization, and the need for multiple islet donors. We describe our experience with an efalizuma...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Turgeon, NA, Avila, JG, Cano, JA, Hutchinson, JJ, Badell, IR, Page, AJ, Adams, AB, Sears, MH, Bowen, PH, Kirk, AD, Pearson, TC, Larsen, CP
Format: Artigo
Idioma:Inglês
Publicat: 2010
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3335736/
https://ncbi.nlm.nih.gov/pubmed/20883542
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1600-6143.2010.03212.x
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!